Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.55 CHF | +0.75% | -0.49% | +14.87% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.87% | 529M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.24% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea to Submit New Drug Application for Bacterial Bloodstream Infections Drug By 2022-end